Dr. Reddys Laboratories Ltd.
BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1234.60
-10.90 (-0.88%) Dr. Reddy's Lab reports Profit after tax of Rs 4490.00 Mln, in the September 2021 quarter
Date: 29-10-2021
A fair growth of 14.27% in the revenue at Rs. 38234.00 millions was reported in the September 2021 quarter as compared to Rs. 33458.00 millions during year-ago period.The Net Profit of the company registered a slight decline of -6.65% to Rs. 4490.00 millions from Rs. 4810.00 millions.Operating Profit saw a handsome growth to 8664.00 millions from 8432.00 millions in the quarter ended September 2021.
(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202109 | 202009 | % Var | 202109 | 202009 | % Var | 202103 | 202003 | % Var | |
| Sales | 38234.00 | 33458.00 | 14.27 | 72569.00 | 65902.00 | 10.12 | 133491.00 | 118504.00 | 12.65 |
| Other Income | 1181.00 | 266.00 | 343.98 | 3043.00 | 6713.00 | -54.67 | 8011.00 | 7432.00 | 7.79 |
| PBIDT | 8664.00 | 8432.00 | 2.75 | 16145.00 | 24166.00 | -33.19 | 39379.00 | 36128.00 | 9.00 |
| Interest | 111.00 | 93.00 | 19.35 | 176.00 | 233.00 | -24.46 | 467.00 | 478.00 | -2.30 |
| PBDT | 8553.00 | 8339.00 | 2.57 | 15969.00 | 23933.00 | -33.28 | 38912.00 | 35650.00 | 9.15 |
| Depreciation | 2066.00 | 2142.00 | -3.55 | 4037.00 | 4119.00 | -1.99 | 8350.00 | 7892.00 | 5.80 |
| PBT | 6487.00 | 6197.00 | 4.68 | 11932.00 | 19814.00 | -39.78 | 30562.00 | 27758.00 | 10.10 |
| TAX | 1997.00 | 1387.00 | 43.98 | 3308.00 | 5502.00 | -39.88 | 8698.00 | -1619.00 | -637.25 |
| Deferred Tax | 841.00 | 273.00 | 208.06 | 1168.00 | 1997.00 | -41.51 | 3297.00 | -6458.00 | -151.05 |
| PAT | 4490.00 | 4810.00 | -6.65 | 8624.00 | 14312.00 | -39.74 | 21864.00 | 29377.00 | -25.57 |
| Equity | 832.00 | 831.00 | 0.12 | 832.00 | 831.00 | 0.12 | 832.00 | 831.00 | 0.12 |
| PBIDTM(%) | 22.66 | 25.20 | -10.08 | 22.25 | 36.67 | -39.33 | 29.50 | 30.49 | -3.24 |